
Keywords: ALD; alcoholic liver disease; AMPK; AMP-activated protein kinase; BGT1; Na+/Clâ-dependent betaine-GABA transporter; BHMT; betaine-homocysteine methyltransferase; DMG; dimethylglycine; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic ste